BMRN icon

BioMarin Pharmaceuticals
BMRN

Overview Fund Activity

391 hedge funds and large institutions have $21.6B invested in BioMarin Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 155 increasing their positions, 128 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
391
Holders Change
+14
Holders Change %
+3.71%
% of All Funds
10.54%
Holding in Top 10
16
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.43%
New
55
Increased
155
Reduced
128
Closed
40
Calls
$329M
Puts
$294M
Net Calls
+$35.5M
Net Calls Change
+$57M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$1.9B
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$372M
3
Temasek Holdings
3
Temasek Holdings
Singapore
$353M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.45B
5
Balyasny Asset Management
5
Balyasny Asset Management
Illinois
$73.6M

Top Sellers

1
Sands Capital Management
1
Sands Capital Management
Virginia
$1.59B
2
Goldman Sachs
2
Goldman Sachs
New York
$34.7M
3
SC
3
Sculptor Capital
New York
$0
4
VAM
4
Visium Asset Management
New York
$0
5
TG
5
TCW Group
California
$148M
Name Holding Trade Value Shares
Change 		Shares
Change %
OI
426
Oakbrook Investments
Illinois
– -$209K -1,675 Closed
Federated Hermes
427
Federated Hermes
Pennsylvania
– -$138K -1,104 Closed
SEC
428
Seven Eight Capital
New York
– -$112K -900 Closed
WAM
429
Wolverine Asset Management
Illinois
– -$68K -550 Closed
BCM
430
Blume Capital Management
California
– -$10K -80 Closed
ZB
431
Zions Bancorporation
Utah
– -$3K -28 Closed
14 15 16 17
18